2 investments found

Single Technologies

SINGLE has developed the world’s fastest DNA sequencing technology at the lowest known cost in the market. This current offering will finalize product development and market entry.
Funded SEK 8,618,970
Target SEK 6,999,980
Capital Target SEK 15,010,000
Min. Raise SEK 6,999,980
Percent of Equity Offered 11%
Valuation of equity SEK 138000000
End Date 30 April 2019
1 Startup Stockholm
View Investment

Athera Biotechnologies

Athera is a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological drugs for treatment of cardiovascular disease.
Funded SEK 54,995,000
Target SEK 30,000,000
Capital Target SEK 60,000,000
Min. Raise SEK 30,000,000
Percent of Equity Offered 55%
Valuation of equity SEK 110000000
End Date 21 April 2019
2 Growth
View Investment